Bond yields traded flat on Tuesday, as Serum Institute of India (SII) CEO Adar Poonawalla said he was hoping for the emergency use approval of AstraZeneca-Oxford University COVID-19 vaccine Covishield by the end of this month or January in the UK and India. FICCI’s report stating that India could benefit from the likely shift in global supply chains from China to other economies in the aftermath of the COVID-19 pandemic, likely to boost sentiments in markets.
Back home, the yields on new 10 year Government Stock were trading flat with its previous close of 5.92% on Monday.
The benchmark five-year interest rates were trading 1 basis point higher at 5.13% from its previous close of 5.12% on Monday.